1. Weight loss and body mass index in advanced gastric cancer patients treated with second-line ramucirumab: a real-life multicentre study
   Alessandro Parisi et al, 2019, Journal of Cancer Research and Clinical Oncology CrossRef
2. Multimodality Treatment in Metastatic Gastric Cancer: From Past to Next Future
   Alessandro Parisi et al, 2020, Cancers CrossRef
3. Primary versus secondary antiemetic prophylaxis with NK1 receptor antagonists in patients affected by gastrointestinal malignancies and treated with a doublet or triplet combination regimen including oxaliplatin and/or irinotecan plus fluoropyrimidines: A propensity score matched analysis
   Alessandro Parisi et al, 2022, Frontiers in Oncology CrossRef